Career Enhancement for Early-Stage Translational Myeloma Researchers
Official title: Career Enhancement Program
Funded at Mayo Clinic Arizona · NIH-11421177 · Data updated 2026-11-12
This grant supports promising young scientists at Mayo Clinic to jumpstart translational myeloma research and develop the skills needed to turn lab findings into practical patient benefits.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Arizona NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 1, 2015 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $117,195 |
| NIH project number | 2P50CA186781-11 |
| Project ID | NIH-11421177 on NIH RePORTER |
Who could benefit from this research
✓Could help
Early-career researchers with a focus on translating myeloma research who are affiliated with Mayo Clinic and have access to mentorship and internal resources.
✕Less likely to help
Direct patient benefit is unlikely for individuals not connected to Mayo Clinic or not pursuing translational myeloma projects in this program.
What this research studies
The Career Enhancement Program helps early-career investigators in Mayo Clinic’s myeloma translational efforts grow their projects and expertise. It provides targeted funding, mentorship, and structured guidance to accelerate promising ideas toward clinical relevance. The program combines internal Mayo support with SPORE resources to foster multidisciplinary training and collaborative experiences that keep patient outcomes in focus. Applicants are typically junior researchers with a passion for translating laboratory findings into therapies and diagnostics for multiple myeloma.
Why it matters
Potential benefit: Patients with multiple myeloma could benefit from faster development of translational research and potential new therapies arising from these emerging investigators’ work.
How similar studies have gone: Past translational training and mentorship programs within cancer centers have helped launch projects that progressed toward clinical impact, though specific Mayo Myeloma SPORE outcomes vary by year.
Where this research is happening
-
Mayo Clinic Arizona
Scottsdale, United States Active
Researchers
- Principal investigator: Fonseca, Rafael — Mayo Clinic Arizona
- Study coordinator: Fonseca, Rafael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.